ViiV Healthcare ranks #1 company in the PatientView ‘Corporate Reputation of Pharma – from the Patient Perspective 2019 – 2020’ survey
The HIV community is at the heart of everything we do at ViiV Healthcare and we are incredibly proud to have been recognised by PatientView’s ‘Corporate Reputation of Pharma – from the Patient Perspective 2019 – 2020’ report as #1 for the seventh consecutive year, achieving top scores across all 12 survey indicators.
Every day, we work hard to design and implement community programmes and clinical trials that focus on breaking down HIV stigma, improving health-related quality of life and supporting people affected by HIV to ensure access to the medicines they need, making progress towards ending the AIDS epidemic by the UNAIDS target of 2030.
We regularly review our activities to ensure we are prioritising the current unmet needs of people living with HIV and those most at risk of the virus. The results of the PatientView report will provide valuable insights that will help us continue to drive breakthroughs towards our ultimate ambition to end AIDS.
To all the individuals and organisations who took the time to participate in the survey and recognise our work and role in the HIV community, we thank you. Your partnership motivates us to continue our work with focus and purpose so that no person living with HIV is left behind.
Harmony Garges, Chief Medical Officer and Stephen Rea, Head of External Affairs and Communications, ViiV Healthcare
Media contacts
For our corporate press office, email: Rachel Jaikaran
OR call +44 7823 523 755
For US-specific media enquiries,email: Audrey Abernathy
OR call +1 919 605 4521
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.
